IFLR1000

Addex Therapeutics Nasdaq listing

29/1/2020
Share offer
Select tab

Completed

29/1/2020

Overview:

  • Swiss pharmaceutical company Addex Therapeutics listed American Depositary Shares (ADS) on Nasdaq.

Natasha Forrest - Researcher

Jurisdictions:

United States
Switzerland

Deal type:

Share offer

Practice area:

Capital markets : Equity

Industry sector:

Pharmaceuticals and life sciences

Firm:
Homburger

Party: Addex Therapeutics (Issuer)

Lawyer: Frank Gerhard

Related deals